-
Planning to Survive
Survivorship care plans can prepare cancer patients to get the best medical care and maintain their quality of life following treatment.
by Carly Flumer
-
A Missed Conversation
Despite national guidelines urging oncologists to bring up risks of infertility posed by cancer treatment, many young cancer patients are never told about these risks or counseled on their fertility preservation options.
by Marcus A. Banks
-
A Modern Family
My diagnosis with colorectal cancer at age 32 affected my fertility. As a result of my experiences, I help others who have been diagnosed with cancer understand their choices related to fertility preservation and their options for becoming a parent.
by Allison Rosen
-
Drinking After a Diagnosis
A study illuminates the alcohol consumption habits of cancer survivors.
by Jen Tota McGivney
-
“Congrats! You Have the ‘Good’ Cancer”
Many people know thyroid cancer as a cancer type with a relatively good prognosis, but the disease still has profound effects on patients and survivors, writes thyroid cancer survivor Carly Flumer.
by Carly Flumer
-
How Disability Insurers Monitor Patients Online
Companies that offer disability insurance may monitor patients' social media accounts to determine if they qualify for the benefits being received.
by Kate Yandell
-
Avoiding Unnecessary Lymph Node Biopsy
A study adds to evidence that many patients with ductal carcinoma in situ do not need to have their lymph nodes removed.
by Cheryl Platzman Weinstock
-
Treating Fear of Recurrence
Cognitive behavioral therapy may help cancer survivors cope with fear of recurrence, some studies say.
by Jon Kelvey
-
Cancer Patients Should Receive Flu Shots
People with cancer are at increased risk of serious complications if they get the flu. Flu shots are safe for this group, and a recent study bolsters evidence of their effectiveness.
by Carly Weeks
-
What to Do About Lymphedema?
In a randomized study, weight loss and home-based exercise did not improve lymphedema symptoms in breast cancer survivors.
by Anna Azvolinsky
Cancer Talk
Treating HER2-ultralow Breast Cancer
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore